Makers Laboratories Limited (MAKERSL.BO)
INR 172.0
(-0.52%)
INR 172.0
(-0.52%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -993 Thousand | -86.19 Million | 184.98 Million | -3.29 Million | 42.26 Million | 53.87 Million |
| Net Income | -62.64 Million | -8.38 Million | 156.88 Million | -3.29 Million | 2.49 Million | 30.16 Million |
| Depreciation & Amortization | 45.44 Million | 42.41 Million | 40.23 Million | 46.1 Million | 19.87 Million | 15.02 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.42 Million | -109.63 Million | 32.34 Million | - | 11.1 Million | 17.43 Million |
| Other non-cash items | 39.35 Million | -10.59 Million | -44.47 Million | -46.1 Million | 8.8 Million | -8.74 Million |
| Investing Cash Flow | -74.58 Million | 12.52 Million | -217.91 Million | - | -84.28 Million | -83.07 Million |
| Investments in PPE | -66.22 Million | -129.07 Million | -98.88 Million | - | -85.89 Million | -89.24 Million |
| Acquisitions | 1.61 Million | 4.02 Million | 6.06 Million | - | 81 Thousand | 337 Thousand |
| Investment purchases | -37 Million | 81.79 Million | -55.96 Million | - | -140.02 Million | -193 Thousand |
| Sales/Maturities of investments | 9 Million | 28.48 Million | 23.81 Million | - | 140.44 Million | 1.02 Million |
| Other Investing Activities | 18.03 Million | 27.29 Million | -92.95 Million | - | 1.11 Million | 5 Million |
| Financing Cash Flow | 72.49 Million | 57.81 Million | 3.28 Million | - | 29.07 Million | 39.17 Million |
| Debt repayment | -22.38 Million | -117.41 Million | -24.52 Million | - | -5.43 Million | -46.97 Million |
| Dividends payments | -6.29 Million | -6.29 Million | -6.29 Million | - | -5.9 Million | -5.73 Million |
| Common Stock Repurchased | - | 103.01 Million | - | - | - | - |
| Common Stock Issuance | - | 147.5 Million | - | - | - | - |
| Other Financing Activities | 60 Million | -69 Million | 34.1 Million | - | 40.41 Million | 91.88 Million |
| Accounts receivables | -1.8 Million | -64.88 Million | 29.92 Million | - | -32.09 Million | 38.34 Million |
| Accounts payables | 86.94 Million | 45.61 Million | -93.01 Million | - | 33.6 Million | -37.91 Million |
| Inventory | -24.83 Million | -74.77 Million | 36.22 Million | - | 9.59 Million | 17 Million |
| Other working capital | -52.87 Million | -15.59 Million | 59.21 Million | - | - | - |
| Cash at beginning of period | 11.59 Million | 23.08 Million | 52.73 Million | 9.62 Million | 21.6 Million | 11.62 Million |
| Cash at end of period | 22.33 Million | 7.22 Million | 23.08 Million | 55.37 Million | 8.66 Million | 21.6 Million |
| Capital Expenditure | -66.22 Million | -129.07 Million | -98.88 Million | - | -85.89 Million | -89.24 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 10.74 Million | -15.86 Million | -29.64 Million | 45.75 Million | -12.93 Million | 9.97 Million |
| Free Cash Flow | -67.22 Million | -215.27 Million | 86.1 Million | -3.29 Million | -43.62 Million | -35.37 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -62.64 Million | -15.42 Million | -13.38 Million | -20.97 Million | -8.38 Million | -2.81 Million |
| Depreciation & Amortization | 45.44 Million | 11.55 Million | 11.32 Million | 11.07 Million | 42.41 Million | 11.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.42 Million | - | - | - | -109.63 Million | - |
| Other non-cash items | 39.35 Million | 26.97 Million | -11.32 Million | -11.07 Million | -10.59 Million | -11.31 Million |
| Investing Cash Flow | -74.58 Million | - | - | - | 12.52 Million | - |
| Investments in PPE | -66.22 Million | - | - | - | -129.07 Million | - |
| Acquisitions | 1.61 Million | - | - | - | 4.02 Million | - |
| Investment purchases | -37 Million | - | - | - | 81.79 Million | - |
| Sales/Maturities of investments | 9 Million | - | - | - | 28.48 Million | - |
| Other Investing Activities | 18.03 Million | - | - | - | 27.29 Million | - |
| Financing Cash Flow | 72.49 Million | - | - | - | 57.81 Million | - |
| Debt repayment | -22.38 Million | - | - | - | -117.41 Million | - |
| Dividends payments | -6.29 Million | - | - | - | -6.29 Million | - |
| Common Stock Repurchased | - | - | - | - | 103.01 Million | - |
| Common Stock Issuance | - | - | - | - | 147.5 Million | - |
| Other Financing Activities | 60 Million | - | - | - | -69 Million | - |
| Accounts receivables | -1.8 Million | - | - | - | -64.88 Million | - |
| Accounts payables | 86.94 Million | - | - | - | 45.61 Million | - |
| Inventory | -24.83 Million | - | - | - | -74.77 Million | - |
| Other working capital | -52.87 Million | - | - | - | -15.59 Million | - |
| Cash at beginning of period | 11.59 Million | 24.08 Million | 37.46 Million | 11.59 Million | 23.08 Million | 14.4 Million |
| Cash at end of period | 22.33 Million | 47.18 Million | 24.08 Million | -20.97 Million | 7.22 Million | 11.59 Million |
| Capital Expenditure | -66.22 Million | - | - | - | -129.07 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 10.74 Million | 23.1 Million | -13.38 Million | -32.56 Million | -15.86 Million | -2.81 Million |
| Free Cash Flow | -67.22 Million | 23.1 Million | -13.38 Million | -20.97 Million | -215.27 Million | -2.81 Million |
003023
IBU
IVR-PB
SHREMETAL
AMR
CTLT